A drug eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. These drug eluting balloon plays an important role in modern healthcare, as it helps deliver medicine to the vessel and prevents neointimal hyperplasia. A drug eluting balloon is coated with anti-proliferative medications and are dispersed in the walls of blood arteries following balloon inflation, which is typically done at minimal pressures. The surface of these balloons carry antiproliferative drugs that are delivered to the vessel wall when inflated. They are used in the U.S. market and have been already approved for use in Europe.
Request Free Sample Copy (Including Full TOC, List of Tables & Figures, Chart) @
https://www.coherentmarketinsights.com/insight/request-sample/2459
Increasing prevalence of coronary artery disease and growing geriatric population across the globe is expected to propel growth of the drug eluting balloon market over the forecast period. For instance, according to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death worldwide, taking an estimated 17.9 million lives each year. CVDs are a group of disorders of the heart and blood vessels and include coronary heart disease, rheumatic heart disease, cerebrovascular disease, and other conditions.
Moreover, increasing adoption of drug eluting balloons, increase in research and development, government initiatives, and increasing awareness regarding heart diseases is expected to boost growth of the drug eluting balloon market. For instance, in November 2020, Boston Scientific received the Food and Drug Administration (FDA) approval of the Ranger drug-coated balloon, developed for the treatment of patients with peripheral artery disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA).
COVID-19 Impact Analysis:
Older people, and those with underlying medical problems such as CVDs, diabetes, cancer, and chronic respiratory disease are at higher risk of developing serious illness from COVID-19. Moreover, older people are prone to coronary artery disease. The majority of people who die of coronary heart disease are 65 or older. While heart attacks can strike people of both sexes in old age, women are at greater risk of dying (within a few weeks). Thus, there is an increasing demand for drug eluting balloon around the world. This in turn is expected to have a positive impact on the growth of the market.
Competitive Landscape:
Major players operating in the global drug eluting balloon market are Biotronik, Surmodics, Inc., Terumo Corporation, Koninklijke Philips N.V., B. Braun Melsungen AG, Cook Medical, Opto Circuits Limited, Medtronic, Boston Scientific Corporation, and Becton, Dickinson and Company (BD), among others.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/2459
Key Takeaways:
The drug eluting balloon market is expected to exhibit a CAGR of 8.2% during the forecast period owing to the introduction of novel products. For instance, in October 2019, Royal Philips launched two new Stellarex drug-coated balloon sizes. The new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons have received approval from the FDA for the treatment of de novo and restenotic lesions in native superficial femoral or popliteal arteries, both arteries in the upper leg.
Among regions, North America, Europe, and Asia Pacific are expected to witness robust growth in the drug eluting balloon market owing to the high prevalence of coronary artery disease, high prevalence of diabetes, growing geriatric population, increasing research and development, and frequent launches and approvals for novel products in these regions.
For instance, in July 2021, Medtronic announced the launch of Prevail drug coated balloon (DCB) catheter in Europe following CE mark. Prevail DCB is used during percutaneous coronary intervention (PCI) procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease (CAD).
Reasons to Buy this Drug Eluting Balloon Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Drug Eluting Balloon market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Drug Eluting Balloon market
➡Leading company profiles reveal details of key Drug Eluting Balloon market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Drug Eluting Balloon market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
Buy This Complete Business Report With Flat 30% Off @
https://www.coherentmarketinsights.com/insight/buy-now/2459
Table of Content
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Impact Analysis
- Key Highlights
- PEST Analysis
- PORTER’s Analysis
- Mergers and Acquisitions
- Epidemiology
- Market Dynamics
- Global Drug Eluting Balloon Market, By Product Type, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Coronary Drug Eluting Balloon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Peripheral Drug Eluting Balloon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Drug Eluting Balloon Market, By End User, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- CATH Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Ambulatory Surgery Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Drug Eluting Balloon Market, By Region, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profiles
- Medtronic *
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Becton, Dickinson and Company
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Boston Scientific Corporation
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cook Medical
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- B. Braun Melsungen AG
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Koninklijke Philips N.V.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Opto Circuits (India) Limited
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Terumo Corporation
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Surmodics, Inc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Biotronik
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Medtronic *
- Analyst Views
- Section
- References
- Research Methodology
- About Us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837